BSE Live
Dec 05, 16:01Prev. Close
661.50
Open Price
659.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 05, 15:59Prev. Close
662.00
Open Price
662.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
654.45 (189)
| Key Financial Ratios of Anthem Biosciences (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | |
| Per Share Ratios | ||||
| Basic EPS (Rs.) | 8.07 | 6.48 | 6.75 | |
| Diluted EPS (Rs.) | 8.04 | 6.48 | 6.75 | |
| Cash EPS (Rs.) | 9.67 | 8.03 | 7.87 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 43.10 | 34.43 | 30.51 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 43.10 | 34.43 | 30.51 | |
| Revenue from Operations/Share (Rs.) | 32.99 | 25.39 | 18.53 | |
| PBDIT/Share (Rs.) | 13.53 | 10.17 | 8.87 | |
| PBIT/Share (Rs.) | 11.93 | 8.71 | 7.75 | |
| PBT/Share (Rs.) | 11.75 | 8.54 | 8.72 | |
| Net Profit/Share (Rs.) | 8.07 | 6.57 | 6.75 | |
| NP After MI And SOA / Share (Rs.) | 8.07 | 6.57 | 6.75 | |
| Profitability Ratios | ||||
| PBDIT Margin (%) | 41.01 | 40.06 | 47.87 | |
| PBIT Margin (%) | 36.17 | 34.30 | 41.84 | |
| PBT Margin (%) | 35.61 | 33.62 | 47.05 | |
| Net Profit Margin (%) | 24.46 | 25.87 | 36.44 | |
| NP After MI And SOA Margin (%) | 24.46 | 25.87 | 36.44 | |
| Return on Networth/Equity (%) | 18.72 | 19.08 | 22.12 | |
| Return on Capital Employed (%) | 26.88 | 23.63 | 23.89 | |
| Return on Assets (%) | 16.07 | 15.31 | 19.12 | |
| Total Debt/Equity (X) | 0.05 | 0.12 | 0.07 | |
| Asset Turnover Ratio (%) | 0.71 | 0.64 | 0.00 | |
| Liquidity Ratios | ||||
| Current Ratio (X) | 5.32 | 4.38 | 8.07 | |
| Quick Ratio (X) | 4.28 | 3.75 | 7.28 | |
| Inventory Turnover Ratio (X) | 6.69 | 8.33 | 0.00 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | |
| Coverage Ratios | ||||
| Interest Coverage Ratios (%) | 73.25 | 59.64 | 74.81 | |
| Interest Coverage Ratios (Post Tax) (%) | 73.25 | 59.64 | 74.81 | |
| Valuation Ratios | ||||
| Enterprise Value (Cr.) | 0.00 | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | |
| EV/EBITDA (X) | 0.00 | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 0.00 | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 0.00 | 0.00 | 0.00 | |
| Earnings Yield | 0.00 | 0.00 | 0.00 |
14.08.2025
Anthem Bio shares surge 5 percent on strong show in CRDMO and specialty business
21.07.2025
Anthem Biosciences shares close with 28% gains on market debut, valued at Rs 41,017 crore
21.07.2025
Anthem Biosciences shares list at 27% premium over IPO price on NSE; should you buy, sell or hold?
21.07.2025